Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors

JOURNAL ARTICLE published August 2017 in Hematology/Oncology Clinics of North America

Research funded by National Institutes of Health (1R01CA178397-01,1R21CA205936-01)

Authors: Ami B. Patel | Thomas O’Hare | Michael W. Deininger